Insider · CIK 0001869391
Douglas Kirk Ways
Files at SPRB (SPRUCE BIOSCIENCES, INC.). First filing -, latest -.
In brief
Douglas Kirk Ways files SEC Form 4 as officer and director at SPRB (SPRUCE BIOSCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Douglas Kirk Ways has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +1,250 | $0.00 | $0 | 1,250 | Jan 21, 2026 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Jan 21, 2026 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 3,750 | Jan 21, 2026 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +266 | - | - | 266 | Jan 21, 2026 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -266 | - | - | 0 | Jan 21, 2026 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +400 | - | - | 400 | Jan 21, 2026 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -400 | - | - | 0 | Jan 21, 2026 |
| Jul 23, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jul 24, 2025 |
Questions about Douglas Kirk Ways
Answered from the filings on this page, as of the latest one.
Is Douglas Kirk Ways buying or selling?
Douglas Kirk Ways has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Douglas Kirk Ways's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas Kirk Ways has 0.
Where does Douglas Kirk Ways file Form 4?
Douglas Kirk Ways has filed Form 4 at SPRB (SPRUCE BIOSCIENCES, INC.) as Interim Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.